Brent is a Professor of Medicine and Human Genetics at McGill University and a Senior Lecturer at King’s College London. He has trained in clinical medicine, human genetics, statistics and epidemiology and is a practicing Endocrinologist.

He was elected to the American Society for Clinical Investigation and the Royal Society of Canada College of New Scholars.

He has worked extensively with drug development teams in industry to use human genetics to identify and validate drug targets. He is a member of GSK’s International Scientific Advisory Board for Human Genetics.

• 

  CEO and Founder in 5 Prime Sciences

  The best medicines start with the best targets